CIMT 2013

Advancing targeted therapies—report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14–16 2013, Mainz, Germany

Mustafa Diken TRON—Translational Oncology at the University Medical Center of Johannes Gutenberg University; Mainz, GermanyCorrespondence[email protected]

Sebastian Attig Medical Department of University Medical Center; Johannes Gutenberg University; Mainz, Germany

Christian Grunwitz TRON—Translational Oncology at the University Medical Center of Johannes Gutenberg University; Mainz, Germany; Medical Department of University Medical Center; Johannes Gutenberg University; Mainz, Germany

Lena Kranz TRON—Translational Oncology at the University Medical Center of Johannes Gutenberg University; Mainz, Germany; Medical Department of University Medical Center; Johannes Gutenberg University; Mainz, Germany

Petra Simon TRON—Translational Oncology at the University Medical Center of Johannes Gutenberg University; Mainz, Germany

Niels van de Roemer TRON—Translational Oncology at the University Medical Center of Johannes Gutenberg University; Mainz, Germany; Medical Department of University Medical Center; Johannes Gutenberg University; Mainz, Germany

Fulvia Vascotto TRON—Translational Oncology at the University Medical Center of Johannes Gutenberg University; Mainz, Germany

Sebastian Kreiter TRON—Translational Oncology at the University Medical Center of Johannes Gutenberg University; Mainz, Germany

show all

Abstract

The 11th Annual Meeting of Association for Cancer Immunotherapy (CIMT) welcomed more than 700 scientists around the world to Mainz, Germany and continued to be the largest immunotherapy meeting in Europe. Renowned speakers from various fields of cancer immunotherapy gave lectures under CIMT2013’s tag: “Advancing targeted therapies” the highlights of which are summarized in this meeting report.

Keywords: :

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Acknowledgments

Authors would like to thank all speakers of CIMT2013 whose lectures formed the basis of this report.

CIMT 2013

Advancing targeted therapies—report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14–16 2013, Mainz, Germany

Information for

Open access

Opportunities

Help and information

CIMT 2013

Advancing targeted therapies—report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14–16 2013, Mainz, Germany

Abstract

Disclosure of Potential Conflicts of Interest

Acknowledgments

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature